GlassScriptPhysician profile
Madison Richard
NPI 1962211623
$1,625.58
in general payments reported to CMS, 2019-2025
16 companies · $1,626 in 2025
The $1,626 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,554 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,553.58 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $375.01 | 2025 | Opzelura, Opzelura |
| Genzyme Corporation | $253.03 | 2025 | |
| Abbvie INC. | $218.98 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $190.11 | 2025 | Dupixent |
| Janssen Biotech, INC. | $147.46 | 2025 | Tremfya |
| Leo Pharma INC. | $79.83 | 2025 | Adbry, Anzupgo |
| Sanofi-Aventis U.S. LLC | $72.00 | 2025 | |
| Ucb, INC. | $60.27 | 2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $60.22 | 2025 | |
| Lilly USA, LLC | $48.41 | 2025 | Ebglyss |
| Amgen INC. | $23.21 | 2025 | Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.88 | 2025 | Spevigo |
| Biofrontera INC. | $22.55 | 2025 | Ameluz |
| E.R. Squibb & Sons, L.L.C. | $19.38 | 2025 | Sotyktu |
| Botanix Sb INC | $17.52 | 2025 | Sofdra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $14.72 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Richard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.